Very good news: the DC Circuit today rejected the effort by two states (Massachusetts and Montana) to invalidate the SEC's rules enacted to implement Regulation A+ and Title IV of the Jumpstart Our Business Startups (JOBS) Act of 2012. We are waiting to review the...

June 19 will be one year since the effectiveness of the SEC's new rules on Regulation A+ under the Jumpstart our Business Startups (JOBS) Act of 2012. So what's happened in the interim? According to information I very recently received: 99 deals filed, of which 55...

We on Wall Street like to think we do important things. Some say it's just moving money from one pocket to another. Others say we are helping finance the next cancer cure or solution to climate change or game-changing new technology. But in the end...

In a significant but not entirely unexpected or surprising blow to the cannabis industry, the Nasdaq stock market has decided to reject the attempt by MassRoots, a social networking site for cannabis enthusiasts, to list on their exchange. The reason: because they may be deemed to...

The SEC's Advisory Committee on Small and Emerging Companies, co-led by Sara Hanks (left), met the other day to talk about how to update the definition of "accredited investor" following a detailed report issued by the SEC back in December. As we know, only accrediteds...

It took four years since the passage of the Jumpstart our Business Startups (JOBS) Act, but it is finally here. Regulation Crowdfunding, approved by the SEC back in October, is now officially in effect. Companies can work with a broker-dealer or registered online portal to...

So much to consider with the passing of nearly 117-year old Susannah Mushatt Jones here in New York City the other day. There's now only one person documented alive who was born before 1900 (Ms. Jones was born in 1899). Though blind in recent years she...

Your humble blogger was honored yesterday to appear on the SiriusXM Business Radio program "The Business of Health" hosted by the very capable Mitch Goldman. The topic: medical marijuana. We had quite the fascinating group of folks interviewed, including doctors, entrepreneurs and yrs truly. It...

In a recent letter to some US Senators, the Drug Enforcement Administration said it's going to decide during the first half of this year whether to reschedule cannabis from a Schedule I drug, currently deemed as dangerous and worthless medically as heroin. In two previous...